by Lisa Nadal | Jun 27, 2022 | 2022, Past Events, Scientific
Philogen will attend the 3rd Annual Cytokine-Based Drug Development Summit in Boston. Roberto De Luca, Head of Antibody Therapeutics, will give a virtual lecture entitled “Antibody-cytokine fusion proteins against Fibroblast Activation Protein (FAP)” on the 28...by last | Jun 27, 2022 | 2022, Past Events
Philogen will attend the 13th World ADC in San Diego (USA) in September 2022. Samuele Cazzamalli, Head of Small Molecules Therapeutics at Philogen, will give a lecture in person entitled “Pan-Tumoral Small Molecule-Drug Conjugates Targeting Fibroblasts Activation...by last | Jun 27, 2022 | 2022, Past Events
Philogen attends ESMO in September 2022. Tobias Weiss, MD/PhD, Neuro-Oncologist at the Universitätsspital Zürich, to give a presentation entitled “The combination of lomustine and antibody-based targeted TNF (L19TNF) as a promising treatment for recurrent...by last | Jun 27, 2022 | 2022, Past Events
Philogen will attend EANO Meeting in Vienna in September 2022. More details on the lecture held by Philogen will follow shortly. Please visit the EANO Meeting Website for additional information.by last | Jun 27, 2022 | Past Events
Philogen attends the Small Molecule Drug Discovery & Synthesis Symposium organized by Janssen in September 2022. Prof. Dario Neri, PhD, CEO and CSO of Philogen, to give a presentation entitled “From Encoded Combinatorial Libraries To Targeted Therapeutics” on the...by last | Jun 27, 2022 | Past Events
Philogen participates at the BIO-Europe 2022 in Leipzig, the international partnering event in the life science and pharma industry, on October 24-26, 2022. Please meet with us in case you are interested in a collaboration or partnership with the Philogen...